Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil
Authors:
- Anna S. NishiyaANAnna S. Nishiya
- José E. LeviJLJosé E. Levi
- Cesar de Almeida‐NetoCACesar de Almeida‐Neto
- Steven S. WitkinSWSteven S. Witkin
- Suzete C. FerreiraSFSuzete C. Ferreira
- Leda BassitLBLeda Bassit
- Ester C. SabinoESEster C. Sabino
- Claudia Di‐Lorenzo‐OliveiraCDClaudia Di‐Lorenzo‐Oliveira
- Vanderson RochaVRVanderson Rocha
- 9 March 2021
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 61 (5) , 1495-1504
Abstract
Background: The present study determined the HBV antigen, antibody, and DNA status in blood donations deemed to be HBV positive. Individuals with an occult HBV infection (OBI), defined as being positive for HBV DNA but negative for HBV surface antigen (HBsAg), as well as those with active infection (HBsAg‐positive), were identified and characterized.Study Design and Methods: From a total pool if 198,363 blood donations, we evaluated in a cross‐sectional study, 1106 samples that were positive in screening tests for antibody to HBV core antigen (HBcAb), HBsAg, and/or HBV DNA by nucleic acid testing (NAT‐HBV). The presence of genetic variants in the HBV pol/S gene in individuals with an active HBV infection was also determined.Results: OBIs were detected in six of 976 samples (0.6%) that were positive only for HBcAb. The rate of HBV active infection was 0.024% (48/198,363) and there was a predominance of HBV sub‐genotype A1 (62.2%, 28/45), followed by D3 (17.8%, 8/45). Mutations in the S gene were found in 57.8% (26/45) and immune escape mutations in 37.8% (17/45) of active HBV‐infected donors. Among them, T123N, G145A, and D144G high‐impact immune escape mutations were identified.Conclusion: Highly sensitive molecular tests improve the capacity to detect OBIs. When NAT is performed in pooled samples, HBcAb test has value in the detection of donors with OBI and improves transfusion safety. Mutations in the S gene are frequent in HBsAg‐positive blood, including those associated with diagnostic failure and vaccine escape mutations.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (grant #2017/16658‐6)
This publication has 41 references indexed in Scilit:
- Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, BrazilVirology Journal, 2013
- Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donorsJournal of Hepatology, 2012
- Impact of Hepatitis B Virus Surface Protein Mutations on the Diagnosis of Occult Hepatitis B Virus InfectionHepatology, 2010
- Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback programTransfusion, 2007
- Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolatesBMC Microbiology, 2007
- Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant VariantsJournal of Virology, 2006
- Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg SubtypesIntervirology, 2004
- Occult hepatitis B virus infection: implications in transfusionVox Sanguinis, 2004
- Descarte de bolsas de sangue e prevalência de doenças infecciosas em doadores de sangue da Fundação Pró-Sangue/Hemocentro de São PauloRevista Panamericana de Salud Pública, 2003
- Significance of isolated hepatitis B core antibody in blood donors from São PauloRevista do Instituto de Medicina Tropical de São Paulo, 2001